Abstract The goals of this study were to document the proliferative response of intestinal stem cells (ISCs) during regeneration after damage from doxorubicin (DXR), and to characterize the signals responsible for ISC activation. To this end, jejuni from DXR-treated mice were harvested for histology, assessment of ISC numbers and proliferation by flow cytometry, crypt culture, and RNA analyses. Histology showed that crypt depth and width were increased 4 days after DXR. At this time point, flow cytometry on tissue collected 1 h after EdU administration revealed increased numbers of CD24 lo UEA − ISCs and increased percentage of ISCs cycling.
Introduction
Intestinal stem cells (ISCs), located in the lower portions of the crypts of Lieberkühn, are responsible not only for intestinal epithelial development and maintenance of epithelial homeostasis but also for restitution of epithelial integrity and function following damage or challenge. Current literature suggests there are two broad categories of ISCs: an actively cycling population found at the crypt base and marked by Lgr5, and one (or more) relatively quiescent population(s) located a little higher in the crypt (Barker et al. 2012; Carlone and Breault 2012; King and Dekaney 2013; Potten et al. 2009; Shaker and Rubin 2010) . The former, herein designated Bactive ISCs^, are believed to be primarily responsible for daily turnover of the epithelium under homeostatic conditions, whereas the latter, designated Breserve ISCs^, appear to function as a source of epithelial replacement and crypt regeneration after intestinal damage. Better understanding of factors that regulate ISC behavior will enlighten future treatment across multiple clinical scenarios. These include, but are not limited to, chemotherapy or radiation-induced mucositis, ischemia-reperfusion injury, short bowel syndrome, IBD/ intestinal inflammation, intestinal polyposis syndromes, and cancer.
As has been previously reported, the commonly used chemotherapeutic agent doxorubicin (DXR) rapidly induces apoptosis in the ISC zone (Dekaney et al. 2009; Ijiri and Potten 1987) . This causes epithelial damage including crypt loss and villus blunting, followed by epithelial regeneration (Dekaney et al. 2009) . A key component of the repair phase is restoration of crypt number, which occurs by the process of crypt fission. Prior studies suggest that crypt fission may be driven by activation of reserve ISCs Dekaney et al. 2009 ); however, data on ISC proliferation were not provided in these reports. Thus, the first goal of our study was to use quantitative flow cytometric analysis following administration of the thymidine analog EdU to directly assess ISC proliferation following damage by DXR.
During both homeostasis and response to damage, the stem cell niche is recognized as providing key regulatory signals to the ISCs (Scoville et al. 2008; Shaker and Rubin 2010; Smith et al. 2012; Tan and Barker 2014; Yu 2013) . The niche includes epithelial elements, such as Paneth cells, which are known to secrete multiple factors capable of enhancing ISC proliferation (Clevers and Bevins 2013) , as well as subepithelial elements, such as myofibroblasts, which secrete both stimulatory and inhibitory factors (Powell et al. 2011; Ye Lei et al. 2014) . While the complex interplay of niche components with ISCs has been widely studied following radiation damage (Yu 2013) , there is a dearth of literature on the regulation of ISC behavior following damage by chemotherapeutic drugs. This represents a major gap in current knowledge of ISCs. Therefore, our second goal was to assess the relative contributions of the crypt epithelium and the underlying tissue, hereafter referred to as sub-epithelial tissue (SET) in eliciting ISC proliferation after DXR-induced damage. We hypothesized that, following cytotoxic damage, ISCs rely on signals from either the crypts themselves and/or from the SET to proliferate and drive crypt fission, thus regenerating the epithelium. This hypothesis was tested using a crypt culture system in which crypts were grown alone or in combination with SET. Candidate ISC-regulating factors secreted by SET in vivo were identified by transcriptome analysis and then tested in crypt culture.
Materials and methods
Damage and repair after DXR: animals, tissue processing, and histology Animal experiments were performed with permission of our IACUC. Mice were housed under a 12:12-h light:dark cycle in American Association for Accreditation of Laboratory Animal Care-approved facilities. After acclimation to our facility for ≥1 week, 20-to 25-week-old male C57BL/6 J mice (Jackson Laboratories, Bar Harbor, ME, USA) were injected IP with DXR (15 mg/kg). Following injection, animals were provided with fresh water and fed standard chow with liquid diet supplementation of Nutren 1.0 with Fiber (Nestlé Health Science, Florham Park, NJ, USA) diluted 2:1 with water. Control mice (uninjected) were maintained on this diet for an equivalent length of time. Mice were weighed daily and sacrificed at 2-day intervals, up to 8 days, after DXR injection. At sacrifice, jejunal tissue was harvested, flushed with icecold PBS and cut into 1-cm lengths. The majority (approx. 18) of these pieces were placed into ice-cold PBS for crypt harvest and SET-co-culture (below). One piece from the midjejunum was incubated in zinc formalin at RT overnight, and then stored in 70 % EtOH at RT until embedded in paraffin, sectioned into 5-μm sections (separated by 100-μm intervals) and stained with hematoxylin and eosin (H&E) for morphological assessment. Another piece from mid-jejunum was filleted open and placed into ice-cold PBS for complete epithelial dissociation to generate SET for RNA isolation. Histological measurements from H&E-stained tissues were taken by a blinded scorer using Image J software (5 sections scored per biological replicate, ≥3 biological replicates per time point); To quantitate crypt fission, 100 well-orientated crypts were examined from each mouse. Crypt fission was defined as a bifurcating crypt with a fissure creating two (or sometimes more) flask-shaped bases with a shared single crypt-villus junction. For all histologic data, statistical comparisons of each time point with day 0 were performed using one-way ANOVA with Tukey multiple comparison test.
Assessment of ISC cycling activity after DXR by flow cytometry
Jejunal epithelial cells were isolated from untreated and day 4 DXR-treated mice using an EDTA/Dispase method, 1 h after IP injection of EdU (100 μg/20 g BW) as described previously (von Furstenberg et al. 2011) . One million cells from the single cell suspension were incubated in 100 μl PBS with no antibody, UEA-488 (1:500), or anti-CD24-PB (0.25 μg/ml), and the EdU coupled with azide Alexa-647 dye following fixation and permeabilization using reagents and methods as reported previously (von Furstenberg et al. 2011) . Cells were analyzed by using a Beckman-Coulter CyAn ADP (Dako, Carpinteria, CA, USA). Debris and CD45 + cells were excluded based on size via bivariate plot of forward scatter (FSC) versus side scatter (von Furstenberg et al. 2011 ). Doublets were excluded by successive gating on both a bivariate plot of pulse-width versus FSC, and a bivariate plot of FSC area versus FSC linear. Fluorescence minus one controls were used to establish gates to measure labeled cells (Roederer 2001) .
Statistical comparisons of cell populations in DXR-treated versus control mice were performed using unpaired t tests (two-tailed).
Crypt culture
Crypts were isolated from jejuni of C57BL/6 J mice via incubation in 5 mM EDTA in PBS at 4°C×30 min on an orbital platform, followed by gentle hand shaking in ice-cold PBS and filtration through a 70-μm cell strainer in a manner similar to Sato et al. (2009) . This crypt-enriched fraction was then pelleted by centrifugation and resuspended in hESCqualified Matrigel (BD, San Jose, CA, USA) containing the anoikis inhibitor Y27632 (Sigma, St. Louis, MO, USA) at a concentration of 10 μM and culture factors epidermal growth factor (EGF) at 50 ng/mL, noggin at 100 ng/mL and Rspondin-1 at 500 ng/mL, as originally reported by Sato et al. (2009) and previously described by Fuller et al. (2013) . Variations in the standard culture factors are indicated in the figure legends. Matrigel aliquots (10 μl per well containing 60-100 crypts) were plated onto 48-well culture plates (Costar, Washington DC, USA). Plates were incubated at 37°C for 30 min for Matrigel polymerization, and 200 μl per well of culture media was added containing Advanced DMEM/F12 supplemented with GlutaMAX (2 mM), gentamycin/kanamycin (1:100), amphotericin B (0.25 μg/mL), HEPES (10 mM), N2 (1:100) and B27 (1:50). On the day of plating, the number of crypts per well was manually counted under bright field microscopy. Plates were then incubated at 37°C, and culture media was changed every 2 days, including supplementation with indicated culture factors to achieve original plating concentrations. There were ≥4 technical replicates per condition tested.
After 7 days in culture, the numbers of enterospheres and enteroids, as defined by the Intestinal Stem Cell Consortium (Stelzner et al. 2012) were counted. Crypt survival per well was calculated as the total number of surviving structures (enterospheres or enteroids) divided by the original number of crypts plated in that well. The number of buds on each surviving structure was counted under bright field microscopy. Enterospheres that survived but failed to progress to enteroids were assigned a bud number of 0. The average bud number per well was calculated as the total number of buds divided by the total number of surviving enteroids and enterospheres per well. Average bud counts from the technical replicates for each mouse were then used to calculate means± SEM for numbers of mice (biological replicates) shown in figure legends. Statistical analysis for Fig. 3 was via unpaired t tests (two-tailed).
For SET co-culture experiments, crypts were isolated from jejuni of DXR-treated mice and untreated controls, and resuspended at equal concentrations into Matrigel containing only R-spondin-1. Remnant tissue from the crypt isolation was then shaken aggressively to remove epithelium and yield SET. The SET was minced finely and added at a concentration of 1.0-1.5 μL minced SET per 50 μL Matrigel-crypt suspension prior to plating and further culture, as described above. After 7 days, bud numbers were quantified as previously described. Statistical analysis for Fig. 4 was as follows: t test (two-tailed) was performed to compare condition A to B; and paired t tests were performed to compare condition A to C, condition A to D, and condition C to D.
In order to study the effects of amphiregulin and noggin, crypts were isolated and plated in Matrigel containing Rspondin-1, as above, in addition to either: A, no further additions; B, recombinant mouse amphiregulin (R&D, Minneapolis, MN, USA) at 100 ng/mL (final concentration); C, noggin at 100 ng/mL (final concentration); or D, both amphiregulin and noggin. Bud numbers were quantified after 7 days in culture. Statistical analysis was performed using two-way ANOVA, with post hoc one-way ANOVA with Tukey multiple comparison test.
To assess the potency of chordin-like 2 as compared with noggin, crypts were grown in Matrigel containing R-spondin-1 and amphiregulin as above in addition to either noggin or chordin-like 2 at concentrations of 0, 10, 100, or 200 ng/mL. Bud numbers were quantified after 7 days in culture. Statistical analysis was performed using two-way ANOVA.
Microarray analysis, gene ontology and qRT-PCR
SET was stored at 4°C in RNAlater (Qiagen, Venlo, Netherlands) then removed and homogenized in a solution of 1:100 β-mercaptoethanol to Buffer RLT Plus (Qiagen) in Lysing Matrix tubes on a FastPrep-24 (MP Biomedicals, Santa Ana, CA, USA). Lysates were centrifuged and RNA was extracted from the supernatant using the RNeasy Plus Mini Kit (Qiagen). RNA from 8 biological replicates per condition (8 SET from untreated controls and 8 SET from day 4 after DXR mice) was submitted for microarray. RNA quality and concentration were assessed using a 2100 Bioanalyzer (Agilent, Santa Clara, CA, USA) and NanoDrop Spectrophotometer prior to submission to the UNC Functional Genomics Core, where total RNA (250 ng) was used to synthesize fragmented and labeled sense-strand cDNA and hybridized onto Affymetrix Mouse Gene 2.1 ST arrays (16-array plate). The Affymetrix HT WT User Manual (Santa Clara, CA, USA) was followed to prepare the samples. Partek Genomics Suite 6.6 (Partek, St. Louis, MO, USA) was used to perform data analysis. Robust multi-chip analysis (RMA) normalization was done on the entire dataset. Multi-way ANOVA and fold change were performed to select target genes that were differentially expressed between DXR SET and untreated SET. Top differentially expressed genes were selected with p value cutoff of <0.05 based on ANOVA test and 2-fold change cutoff. Hierarchical Clustering was performed on differentially expressed genes based on Average Linkage with Pearson's Dissimilarity. Gene Ontology enrichment analysis on the gene lists were performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID). To determine GO term enrichment, the proportion of test genes that mapped to a particular GO term was compared with the proportion of genes from the entire GeneChip that mapped to the same term. Enriched biological process and cellular component terms shown had a p value and FDR cutoff of <0.05. The selected regenerative candidate terms in the cross-comparison met the criteria of p value <0.05.
To validate the microarray data and examine the time course of expression of selected transcripts in SET following DXR treatment, RNA was prepared from SET collected at days 0, 2, 4, 6, and 8 after DXR injection. For highthroughput qRT-PCR, cDNAwas synthesized from RNA, amplified, and included for gene expression analysis using the Fluidigm BioMark HD system according to the manufacturer's instructions (Fluidigm, South San Francisco, CA,
, and Nog (Mm01297833_s1) were obtained from Life Technologies (Grand Island, NY, USA) and used according to the manufacturer's protocol. β-Actin was used as an internal control, and fold changes were obtained using the comparative [delta] [delta]Ct method. mRNA fold changes of the DXR-treated groups (days 2, 4, 6, 8 following administration) were then normalized to corresponding day 0 (untreated) values, setting the control fold change to a baseline value of 1. One-way ANOVA was performed to assess statistical significance of these mRNA fold changes across the time points.
Results
The regenerative response to damage becomes evident by 4 days after DXR As expected, treatment with DXR produced mucositis in our mice, associated with weight loss and changes in crypt number/crypt morphology. Following IP injection, the weight loss was rapid in the first 4 days, then plateaued (Fig. 1a) . Crypt loss occurred, wherein the number of crypts per transverse jejunal circumference declined significantly by day 4 after DXR (Fig. 1b) ; this was accompanied by a decline in total jejunal circumference, though this did not reach significance (Fig. 1c) . By day 4 after DXR, there was morphological evidence of crypt regeneration, with increased crypt depth (Fig. 1d) , and width (Fig. 1e) . This was followed by a significant increase in the rate of crypt fission at day 8 (Fig. 1f) , indicating a definitive stage of damage recovery. Representative histology is shown in Fig. 1g at low power and at high power in Supplemental Fig. 1 . Collectively, these data led us to further characterize events occurring at day 4 after DXR, as this seemed a likely time point in which regenerative signaling to ISCs would be strong.
ISC numbers and proliferation status are elevated 4 days after DXR Previous work from our laboratory has shown that following staining of epithelial preparations with CD24, both ISCs and Paneth cells are found in the CD24 lo fraction identified by flow cytometry (von Furstenberg et al. 2011) . Wong et al. (2012) subsequently demonstrated that the lectin UEA can be used to remove Paneth cells. Thus, in the current work, flow cytometry was used to exclude UEA + cells; the UEA − population was then plotted as CD24 versus EdU (to identify cycling cells). Representative flow plots are shown in Fig. 2a and the labeling strategy is shown in Fig. 2b . There was an expansion in the absolute pool of ISCs (both cycling and noncycling): ISCs represented 4.9±1.0 % of all epithelial cells at day 4 after DXR versus 2.2±0.6 % in untreated controls (Fig. 2c ). This was accompanied by increased cycling activity of ISCs at day 4 after DXR: 37±6 % of ISCs were cycling at this time point, as compared to 17±4 % in untreated controls (Fig. 2d) . Interestingly, this expansion in cycling activity demonstrated a preserved ratio between cycling transit amplifying (TA) cells and cycling ISCs (Fig. 2e) ; 4 days after DXR 28± 5 % of EdU + epithelial cells were ISCs and 72±5 % of EdU + cells were TA cells (vs. 27±3 % and 73±3 %, respectively, in untreated controls). Overall, these findings point to day 4 after DXR as a time in which ISCs were more actively cycling, and potentially responding to regenerative niche stimuli.
A minimalistic crypt culture system to study crypt responses to exogenous stimuli
In order to explore the origin of regenerative signals to the intestinal epithelium following DXR damage, we needed a culture system in which crypts maintained adequate and reproducible survival, but minimal budding such that the enhanced proliferation could be easily measured. Thus, the standard culture conditions (Sato, et al. 2009 ) were modified as shown in Fig. 3 . As can be seen, with R-spondin-1 only there was good survival after 7 days but minimal budding. Notably, there was an absolute requirement for R-spondin-1, as the absence of this factor yielded enterospheres by 24 h (data not shown), but 0 % survived by 7 days in culture (Fig. 3a) . These data highlighted an important consideration moving forward: by minimizing buds per enteroid while maintaining a reasonable survival, minimalistic culture conditions allow easier testing of potential pro-proliferative factors. Crypts isolated from regenerating intestine are not endogenously more proliferative Figure 4a , b show the behavior of crypts isolated from control mice as compared with mice on day 4 following DXR. As expected, crypts harvested from untreated control mice were minimally proliferative in these culture conditions (1.4±0.3 buds per enteroid). Because ISCs showed enhanced proliferation in vivo 4 days after DXR (Fig. 2) , we hypothesized that crypts isolated from DXR-treated mice would demonstrate increased budding in culture. Surprisingly, this was not observed, as crypts from these mice were also minimally proliferative (1.2±0.3 buds per enteroid).
Sub-epithelial tissue isolated from regenerating intestine increases crypt budding shows that co-culture of SET harvested from mice 4 days after DXR yielded an additional significant increase in budding of control crypts (5.1±1.0 buds per enteroid). This suggested that SET releases stimuli which induce epithelial proliferation, and that these signals are heightened during repair from cytotoxic injury.
Transcriptome analysis reveals regenerative signals originating from SET after damage
Microarray analysis performed on RNA extracted from SET harvested from mice 4 days after DXR as compared to untreated controls revealed 1030 differentially regulated genes (listed in Supplemental Table 1 ). Hierarchical clustering showed clear distinctions between treatment groups (Fig. 5) . Overall GO analysis of biological processes (Fig. 6a) showed enrichment for transcripts expected to be associated with response to damage (e.g., Bresponse to stimulus^, Bresponse to stress^, etc.) and immune infiltration (Binflammatory response^) as well as those associated with repair (e.g., Bcell cycle^, BM phase^, etc.). Within the cellular component arm of GO, the 2 most abundant categories were Bextracellular region^and Bextracellular space^ (Fig. 6b) , consistent with SET being highly secretory, as already deduced from the coculture experiment. In order to identify specific candidate genes, the GO terms Bbinding,^Bextracellular region,^and Btissue development^were considered relevant to ISC activation. As can be seen in Fig. 6c , when these were combined a total of 10 genes emerged. Of these (shown in Fig. 6d ), the most up-regulated was the EGF family member amphiregulin, (7.53-fold enriched) and the third highest was the BMP antagonist chordin-like 2 (4.5-fold enriched). Given the growing body of literature implicating amphiregulin in intestinal epithelial regulation (Hitch et al. 2012; Shao and Sheng 2010) , and mounting evidence that ErbB receptor status may regulate ISC activation (Powell et al. 2012; Wong et al. 2012 ), we selected amphiregulin as an attractive candidate to test in culture for its ability to elicit crypt proliferation. Further, in view of the elevated expression of chordin-like 2, we explored the potential beneficial role of concomitant BMP antagonism.
Amphiregulin increases crypt budding in vitro provided BMP signaling is inhibited
To assess the proliferative capacity of amphiregulin in our enteroid culture system, crypts were grown under minimal conditions (as in Fig. 3 ) with the addition of either amphiregulin alone or amphiregulin in combination with noggin which is the standard BMP antagonist traditionally used in enteroid cultures (Sato and Clevers 2013) . Despite the fact that amphiregulin transcripts were 7.5-fold increased in SET harvested 4 days after DXR (Fig. 6) , the culture data shown in Fig. 7 (a vs. b) show that recombinant amphiregulin alone does not recapitulate the stimulatory effect of day 4 SET observed in Fig. 4 . Likewise, despite the 4.5-fold increase in chordin-like 2 expression, inhibition of BMP signaling via the analogous antagonist noggin was insufficient to elicit crypt budding (Fig. 7 c vs. a) . However in the presence of amphiregulin and noggin there was a dramatic stimulation of the crypts, with average bud numbers (6.3±0.5 buds per enteroid) mirroring those seen with day 4 SET (Fig. 4) . Not only did the one-way ANOVA show significance of the combination treatment (Fig. 7 d vs. c) , but the two-way ANOVA showed a highly significant interaction of amphiregulin and noggin (p<0.001), thus documenting the obvious synergism between these two factors.
In biochemical studies noggin and chordin-like 2 have been shown to have equivalent potencies for inhibition of purified BMP4 (Nakayama et al. 2004) which is the principal BMP found in the tissue underlying intestinal crypts (Haramis et al. 2004; He et al. 2004 ). However, the influence of chordinlike 2 has not been previously studied in the intestinal epithelium. Thus, after observing the importance of BMP antagonism using noggin in Fig. 7 , we directly compared the potency of these two BMP antagonists as facilitators of the proliferative response to amphiregulin. As can be seen in Fig. 8 , the dose response of crypt budding was very similar using chordin-like 2 as compared with noggin. This indicates that elevated expression of chordin-like 2 in SET in vivo is likely to have a functional role in the regenerative response to DXR.
Time course of elevated expression of amphiregulin and chordin-like 2
In order to more carefully assess the potential roles of amphiregulin and chordin-like 2 in the regenerative response in vivo, we used quantitative RT-PCR to examine the time course of elevated expression of these factors and their family members. As can be seen in Fig. 9a , amphiregulin mRNAwas rapidly induced, peaking at day 2 after DXR. Transcripts of two other EGF family members, namely epiregulin and transforming growth factor α (TGFα), were also significantly elevated with a similar time course, but to only modest levels when compared with amphiregulin. Interestingly, EGF mRNA levels in the SET showed no significant change following DXR treatment. All three BMP antagonists examined (Fig.9b) showed induction in response to DXR with a slower time course than the EGF family. Of the three, chordin-like 2 is clearly the dominant transcript with increases exceeding 25-fold at day 4 and exceeding 100-fold at day 6.
Discussion
The primary goal of this study was to characterize the role of the ISC niche in eliciting epithelial repair after damage from DXR. To this end, we initially determined a time point-day 4 after DXR-in which regenerative signaling was likely to be Fig. 3 with added amphiregulin as in Fig. 7 and with various concentrations of either noggin (NOG) or chordin-like 2 (CHRDL2). Each panel shows buds per enteroid as means±SEM, n=2. Two-way ANOVA showed a significant effect of dose (p<0.001), but no significant difference between noggin and chordin-like-2 (p>0.1) and no significant interaction (p>0.4) d shows the fold increase of the 10 transcripts identified in (c) and arrows show the 2 secreted factors chosen to study with cultured crypts, i.e., amphiregulin and chordin-like 2 strong. Next, we demonstrated increased ISC numbers and proliferation at this time, with a concomitant proportional increase in transit amplifying cell proliferation. We then used tightly controlled crypt culture conditions to show that crypts isolated from regenerating tissue (day 4 after DXR) were not inherently more proliferative, but that SET isolated from regenerating tissue was capable of enhancing enteroid budding. Transcriptome analysis of SET revealed candidate factors that may control epithelial responses to damage. Two of these factors, amphiregulin and chordin-like 2, were tested in culture and were shown to have a dramatic combined effect on crypt expansion.
Although previous work has demonstrated increased epithelial proliferation after DXR (Dekaney et al. 2009 ), the focus of the current study was specifically on the ISC fraction of the epithelium. Our quantitative flow cytometric analysis with anti-CD24 and UEA showed greater than 2-fold increases in both the number of ISCs and the proportion of the ISC pool that were actively cycling. While there have been extensive studies on the responses of ISCs following radiation (Hua et al. 2012; May et al. 2008; Metcalfe et al. 2014; Potten 2004; Powell et al. 2012; Van Landeghem et al. 2012; Yan et al. 2012; Yu 2013) , our work constitutes the first detailed report of ISC behavior following DXR damage. Interestingly, two prior studies had pointed to the possibility that the reserve ISC fraction is activated in the regenerative phase after DXR treatment. First, Dekaney et al. (2009) reported increased numbers of side population cells that have subsequently been shown to be noncycling under homeostatic conditions (von Furstenberg et al. 2013) . However, proliferation of this population in response to DXR has not been investigated. The other published study of ISCs after DXR is that by Buczacki et al. (2013) which reported lineage tracing from the label-retaining reserve ISC pool. While this implies proliferation, no quantitative data were provided (in fact only a single positive mouse was reported). In our work, the CD24 lo fraction appears to include both active and reserve ISC populations von Furstenberg et al. 2011) . As such, the increased EdU incorporation at day 4 after DXR likely represents both activation of the reserve ISCs and increased proliferation of the active ISC population. Interestingly, we found that the ratio of cycling ISCs to cycling TA cells was maintained between day 4 after DXR and untreated conditions. This suggests tight biological regulation, and merits further investigation into mechanisms that control this proportional expansion.
In order to assess the role of epithelial versus stromal factors in eliciting proliferation of ISCs after DXR damage, we turned to an in vitro approach. In recent years, Matrigel-based ISC and intestinal crypt cultures have emerged as powerful techniques with which to study ISC behavior ex vivo (Leushacke and Barker 2014; Sato and Clevers 2013; Sato et al. 2009 ), in the absence of the complex and intertwined forces at play in vivo. In such cultures, crypts initially form enterospheres that progress to budding structures termed enteroids (Stelzner et al. 2012) . Bud number has been established as a reliable and reproducible method of assessing crypt proliferation in culture (Fuller et al. 2012) . While traditional crypt cultures have multiple factors designed to optimize proliferation, for the current work we needed to minimize proliferation in order to observe the hypothesized enhancement of proliferation with tissues from DXR-treated mice. Similar to the report by Chen et al. (2012) using crypts from the distal intestine, in our jejunal crypt cultures, we found that in lieu of the standard combination of EGF, noggin and R-spondin-1, R-spondin-1 alone allowed survival but minimal budding. Fig. 9 Quantitative RT-PCR analysis of RNA from SET harvested at 2, 4, 6, and 8 days following DXR administration for select EGF family members and BMP antagonists relative to untreated SET. a EGF members shown include amphiregulin (Areg), epiregulin (Ereg), and transforming growth factor alpha (Tgfa). b Inhibitors of BMP analyzed include chordin-like 2 (Chrdl2), gremlin 1 (Grem1), and noggin (Nog). Bars show mean±SEM, n=3-5. All factors shown have p<0.05 by oneway ANOVA Using these conditions, despite in vivo evidence of increased epithelial and ISC proliferation during repair from DXR-induced epithelial damage, we observed no difference in endogenous in vitro proliferative capacity of crypts isolated from mice before versus after DXR damage (Fig. 4) . However, the addition of SET from recovering intestine yielded a significant increase in enteroid budding, suggesting that regenerative stimuli may originate from below the epithelium. Although we have not identified which cells within the SET survive over the 7 days of incubation, prior studies have demonstrated that myofibroblasts can grow in these Matrigel cultures (Kabiri et al. 2014; Ye Lei et al. 2014) . As discussed below, myofibroblasts are a likely source of the two prime candidates for eliciting crypt budding. To put the co-culture data in the appropriate context, a key point is that each enteroid bud typically has all the features of a new crypt (Sato et al. 2009 ). Thus, we believe the process of budding is the in vitro approximate of in vivo crypt fission, which is a critical component of repair after damage (Wright 2000) . Moreover, since crypt fission is believed to be driven by a doubling of the number of ISCs (Totafurno et al. 1987) , our observed SET effect suggests that by day 4 after DXR, stromal elements are secreting factors which enhance ISC proliferation.
Microarray analysis of the SET (Figs. 5, 6) revealed two attractive candidate factors that may contribute to ISC proliferation after damage. amphiregulin, a member of the EGF family of proteins, is known to be pro-proliferative and to play a central role in repair and branching morphogenesis in various tissues (Berasain and Avila 2014) . On the other hand, chordin-like 2 is a BMP antagonist (Nakayama et al. 2004) and thus would be expected to have a permissive effect on proliferation by blocking the inhibitory actions of BMP signaling. Prior studies in the intestine demonstrated upregulation of amphiregulin during regeneration after whole body irradiation, where amphiregulin production was localized to intestinal sub-epithelial myofibroblasts (Shao and Sheng 2010) . Further, using amphiregulin knockout mice, it was shown that crypt proliferation was unaltered in amphiregulin −/− mice at baseline but significantly hindered following irradiation, highlighting the importance of this molecule, specifically in the context of damage response. Chordin-like 2 has not been previously reported in the small intestine. However, other BMP antagonists, namely gremlin1, gremlin2, and chordin-like 1, have been shown to be produced by myofibroblasts at the bases of colonic crypts, where they are thought to enhance proliferation of epithelial cells, including stem cells, in that location (Kosinski et al. 2007; Powell et al. 2011 ). In addition, over-expression of noggin, another member of the BMP antagonist family, can lead to both crypt fission (Batts et al. 2006 ) and de novo crypt formation (Haramis et al. 2004 ). The same outcomes are observed when BMP signaling is blocked by ablation of BMP receptors (Auclair et al. 2007; He et al. 2004 ).
Based on this literature, we expected amphiregulin to increase proliferative activity of jejunal crypts in vitro and for BMP antagonism to possibly enhance this effect. Interestingly, under the culture conditions used (Fig. 7) , addition of recombinant amphiregulin alone did not increase enteroid budding. However, in the presence of both amphiregulin and BMP antagonism (using either noggin or chordin-like 2), there was dramatic stimulation, yielding bud numbers equivalent to those seen during co-culture with SET isolated 4 days after DXR (Fig. 4) . The fact that the proliferative effect of amphiregulin only became apparent when BMP signaling was inhibited implies the presence of BMPs in this culture system. Since stromal elements, which are the usual source of BMPs in vivo (Haramis et al. 2004; He et al. 2004) , were not included in the study shown in Fig. 7 , the most likely source of BMPs is the Matrigel (Paralkar et al. 1992 ). In intact tissue, endogenous BMPs in the lamina propria would play an analogous role. Thus, we propose that the increases in expression of amphiregulin and chordinlike 2 observed in SET in vivo are responsible for the increased ISC proliferation observed at day 4 after DXR. Confirmation of this suggestion will require demonstration that pharmacologic or genetic ablation of amphiregulin or chordin-like 2 prevents the ISC regenerative response following DXR. Such studies are a logical future direction.
Our qRT-PCR study revealed some interesting nuances (Fig. 9) . First, within the EGF family, two other members, namely epiregulin and TGFα, were up-regulated following DXR. Transcript levels of all three EGF family members peaked at day 2 and remained elevated at day 4. However, at both these time points. it was clear that amphiregulin was the dominant mRNA, with induced levels being 5-to 6-fold and 9-to 12-fold higher than those of epiregulin and TGFα, respectively. Likewise, although statistical analyses indicated that the three BMP antagonists (chordin-like 2, gremlin 1, and noggin) were all up-regulated in response to DXR damage, only chordin-like 2 displayed a robust increase likely to have biological significance. Taken together, our findings point to a novel mechanism that may be critical for repair of the intestinal epithelium following various insults. Further, our demonstration of the potent synergism between amphiregulin and BMP antagonism in stimulation of enteroid budding in vitro, suggests that in vivo these two pathways may provide the driving force for ISC activation and, subsequently, restoration of crypt number via crypt fission. The fact that the surge of chordin-like 2 expression was delayed as compared with that of amphiregulin suggests that continued BMP antagonism may be important in allowing the progression from ISC activation to crypt fission. Further studies to elucidate the cellular and molecular biology of these processes are clearly warranted, and have obvious translational applications.
While our transcript analyses of SET following DXR led us to focus on two families of factors that are likely secreted by myofibroblasts, we recognize that the cellular response to the DXR damage is complex. For example, one cannot overlook the importance of the inflammatory reaction elicited by epithelial compromise, and the role that immune cells play in orchestrating tissue responses. Indeed, blinded scoring of tissue sections following DXR revealed an acute inflammatory response (see high-power images in Supplemental Fig. 1 ). The possibility that these immune cells influence ISC behavior, either by direct signaling to ISCs, or by indirect signaling though myofibroblasts or other cell types, deserves further attention, but was beyond the scope of the current study.
Looking to the future, our current findings, together with previous work that has pointed to reserve ISCs as being the regenerative source of new crypts, suggest two translational applications. The first is the combined delivery of an EGF family member with a BMP antagonist to accelerate the in vivo activation of reserve ISCs following intestinal damage, thus limiting the extent and duration of epithelial compromise. The second is the use of similar combinations of these factors to propagate reserve ISCs in vitro for use in transplantation. To date, ISC culture protocols have been optimized for expansion of the active subpopulation of ISCs. While reserve ISCs typically grow under these conditions, their biology may be abnormal. Thus, full exploration of the signaling pathways operative in vivo, and application of these to generate culture conditions that preserve normal behavior of the reserve ISC fraction, may be of significant value to the field of tissue engineering.
